Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

Clinical trial NCT00347048 · COMPLETED

Trial details

NCT number: NCT00347048
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2006-09-01
Primary completion: 2008-04-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.